HomeBMGL • NASDAQ
Basel Medical Group Ltd
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(SGD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 2.49M | 5.81% |
Operating expense | 710.92K | 10.06% |
Net income | 373.11K | -36.74% |
Net profit margin | 14.98 | -40.22% |
Earnings per share | — | — |
EBITDA | 139.60K | -78.82% |
Effective tax rate | -59.96% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(SGD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.04M | 55.26% |
Total assets | 16.31M | 6.03% |
Total liabilities | 8.75M | -11.57% |
Total equity | 7.56M | — |
Shares outstanding | 16.25M | — |
Price to book | 8.87 | — |
Return on assets | 2.03% | — |
Return on capital | 2.49% | — |
Cash Flow
Net Change in Cash
Net change in cash
(SGD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | 373.11K | -36.74% |
Cash from operations | 1.18M | 54.57% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | -678.99K | 21.63% |
Net change in cash | 503.74K | 593.68% |
Free cash flow | 140.07K | -71.52% |
Previous close
$4.17
Day range
$4.10 - $4.30
Year range
$3.63 - $5.50
Market cap
79.06M USD
Avg Volume
129.21K
P/E ratio
49.04
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2023
Website
Employees
32